HIV Exposure: Understanding Post-Exposure Prophylaxis (PEP)

Post-exposure prophylaxis (PEP) is a 28-day course of antiretroviral drugs started urgently after potential HIV exposure to prevent establishment of infection. It is a medical emergency—every hour of delay reduces efficacy.

When to Initiate PEP

  • Occupational: Needlestick, mucous membrane splash, non-intact skin contact with blood/body fluids from HIV+ or unknown status source.
  • Non-occupational (nPEP): Sexual assault, condomless sex with HIV+ partner not virally suppressed, needle-sharing, other high-risk exposures.

Time window: Ideally ≤2 hours; up to 72 hours (3 days) post-exposure. After 72 hours, PEP is not recommended (insufficient evidence).

Risk Assessment (Determines Urgency)

Exposure TypeSource HIV+ / VL UnknownSource HIV+ / VL Undetectable
Receptive anal sexStrongly recommendGenerally not needed (U=U)
Insertive anal sexRecommendGenerally not needed
Receptive vaginal sexRecommendGenerally not needed
Insertive vaginal sexConsiderGenerally not needed
Needle sharingStrongly recommendConsider
Needlestick (hollow bore)RecommendConsider
Splash to mucous membraneConsiderGenerally not needed

Recommended Regimens (US CDC / WHO Guidelines)

Preferred (3-drug)

  • Tenofovir DF 300 mg + Emtricitabine 200 mg (Truvada®) ONCE DAILY
    PLUS Raltegravir 400 mg TWICE DAILY OR Dolutegravir 50 mg ONCE DAILY OR Darunavir 800 mg + Ritonavir 100 mg ONCE DAILY
  • Alternative: TAF/FTC (Descovy®) + DTG or RAL.

Special Populations

  • Pregnancy: TDF/FTC + RAL (DTG neural tube defect concern at conception; safe after 1st trimester).
  • Children: Weight-based dosing; DTG approved ≥4 weeks/≥3 kg.
  • Renal impairment (eGFR <60): Avoid TDF; use TAF or ABC/3TC + DTG/RAL.

Accessing PEP

  • Emergency Department: 24/7 access; starter packs often available.
  • Sexual health / HIV clinics: Often same-day appointments.
  • Occupational health: For workplace exposures.
  • Telehealth: Increasingly available for nPEP initiation.

Follow-Up & Monitoring

  1. Baseline: HIV Ag/Ab, HIV RNA, renal/hepatic function, pregnancy test, STI screen.
  2. Adherence counseling: Critical for efficacy; manage nausea (common with DTG/RAL).
  3. 4–6 weeks: HIV test.
  4. 3 months: HIV test (definitive exclusion).
  5. 6 months: Optional if high-risk exposure or seroconversion symptoms.

Key Points

  • PEP is not 100% effective; failure associated with delayed start, non-adherence, resistant virus, re-exposure.
  • Side effects: GI upset, headache, fatigue; usually transient.
  • Transition to PrEP if ongoing risk.
  • Source testing: Rapid HIV test on source (if known) informs need for PEP continuation.

HIV & AIDS - Related Articles